Janssen

SIMPONI ARIA

Manufacturer:

Janssen

Simponi Aria HCPCS:

J1602

HCPCS Code Descriptor:

Injection, golimumab, 1 mg, for intravenous use

Category:

J Code

Simponi Aria NDCs:

57894-0350-01

Primary Type:

Immunology:Anti-TNF

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Simponi Aria:

SIMPONI ARIA is an Immunology:Anti-TNF drug manufactured by Janssen and administered via the Intravenous route of administration. The J Code: J1602 is aligned to the drug SIMPONI ARIA.

Simponi Aria is a type of medication called a TNF-blocker and may be used to treat a variety of autoimmune conditions. Simponi Aria may be prescribed to patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, polyarticular juvenile idiopathic arthritis. Simponi Aria may help relieve certain symptoms associated with these autoimmune disorders, including pain, swelling, and damage to healthy parts of the body.

ACCESS PRICING AND MORE BY REGISTERING

J1602 Added Date:

January 1, 2014

J1602 Effective Date:

January 1, 2014

J1602 Termination Date:

HCPCS Active

Simponi Aria billing and coding information can be found through Janssen at the link below:
Simponi Aria patient assistance information can be found through the Johnson and Johnson Patient Assistance Foundation at the URL: http://www.jjpaf.org/
SIMPONI ARIA prescribing information can be found at the link below:
Information regarding SIMPONI ARIA’s side effects can be found at MedlinePlus